riluzole has been researched along with Weight Loss in 2 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Weight Loss: Decrease in existing BODY WEIGHT.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aziz, NA | 1 |
| van der Burg, JM | 1 |
| Landwehrmeyer, GB | 1 |
| Brundin, P | 1 |
| Stijnen, T | 1 |
| Roos, RA | 1 |
| Limousin, N | 1 |
| Blasco, H | 1 |
| Corcia, P | 1 |
| Gordon, PH | 1 |
| De Toffol, B | 1 |
| Andres, C | 1 |
| Praline, J | 1 |
1 trial available for riluzole and Weight Loss
| Article | Year |
|---|---|
Weight loss in Huntington disease increases with higher CAG repeat number.
Topics: Adult; Aged; Animals; Body Mass Index; Body Weight; Disease Models, Animal; Energy Intake; Female; H | 2008 |
1 other study available for riluzole and Weight Loss
| Article | Year |
|---|---|
Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS.
Topics: Aged; Amyotrophic Lateral Sclerosis; Body Mass Index; Female; Humans; Linear Models; Male; Malnutrit | 2010 |